Skip to content
Screener

Ginkgo Bioworks DNA Q2 2025 earnings

Reported August 7, 2025 · After market close

Revenue$49.6MBeat by $10.7M
EPS-$1.10Beat by $0.34
Revenue estimate$38.9M
EPS estimate-$1.44

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$21.6M
EPS estimate-$0.58

Financials

Q2 2025

Income statement

See full
Revenue$39.1M-30.4%
Gross profit$33.8M—
Operating income-$58.2M+73.9%
Net income-$60.3M+72.2%
EPS (diluted)-$1.10+74.0%

Balance sheet

See full
Cash & equivalents$251.4M-67.6%
Total debt$428.8M+91.5%
Total equity$613.0M-26.4%
Total assets$1.2B-24.3%

Cash flow

See full
Operating cash flow-$40.3M+52.3%
CapEx$38.0K-99.9%
Free cash flow-$40.3M+63.8%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$537.91M-27.2%
Enterprise value$715.38M+282%
P/S2.6×-1.5×

Profitability

See full
Operating margin-141.7%-58.3pp
Net margin-149.9%-61.3pp
FCF margin-130.4%-30.6pp

Returns & leverage

See full
Return on equity-43.6%-13.2pp
Debt / equity0.7×+0.4×
Current ratio5.4×+0.7×

FAQ

When did Ginkgo Bioworks report Q2 2025 earnings?
Ginkgo Bioworks (DNA) reported Q2 2025 earnings on August 7, 2025 after market close.
What were Ginkgo Bioworks's Q2 2025 revenue and EPS?
Ginkgo Bioworks reported revenue of $49.6M and eps of $-1.10 for Q2 2025.
Did Ginkgo Bioworks beat estimates in Q2 2025?
Revenue beat the consensus estimate of $38.9M by $10.7M. EPS beat the consensus estimate of $-1.44 by $0.34.
How did Ginkgo Bioworks's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 11.7% from $56.2M a year earlier and eps grew 65.6% from $-3.20.
Where can I find Ginkgo Bioworks's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-038981) and the 10-Q periodic report (0001628280-25-038982) directly on SEC EDGAR. The filing index links above go to sec.gov.